Slide Twelve:

This slide shows the prophylactic recommendations for prevention of DVT for patients undergoing orthopedic procedures on the lower extremities. These recommendations are based on best medical evidence reviewed by a selected committee of the American College of Chest Physicians. Both Fragmin ® (dalteparin) and Lovenox ® (enoxaparin) are approved for prophylaxis of DVT after hip replacement. The dalteparin dose is 5000 IU daily for at least 7-10 days after surgery. The enoxaparin dose is 30 mg twice a day for at least 7-10 days after surgery.

Previous slide

Next slide

Back to first slide

View graphic version